Literature DB >> 9573043

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.

N Bucay1, I Sarosi, C R Dunstan, S Morony, J Tarpley, C Capparelli, S Scully, H L Tan, W Xu, D L Lacey, W J Boyle, W S Simonet.   

Abstract

Osteoprotegerin (OPG) is a secreted protein that inhibits osteoclast formation. In this study the physiological role of OPG is investigated by generating OPG-deficient mice. Adolescent and adult OPG-/- mice exhibit a decrease in total bone density characterized by severe trabecular and cortical bone porosity, marked thinning of the parietal bones of the skull, and a high incidence of fractures. These findings demonstrate that OPG is a critical regulator of postnatal bone mass. Unexpectedly, OPG-deficient mice also exhibit medial calcification of the aorta and renal arteries, suggesting that regulation of OPG, its signaling pathway, or its ligand(s) may play a role in the long observed association between osteoporosis and vascular calcification.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573043      PMCID: PMC316769          DOI: 10.1101/gad.12.9.1260

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  37 in total

1.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

2.  Chemical and physicochemical studies on the mineral deposits of the human atherosclerotic aorta.

Authors:  K Schmid; W O McSharry; C H Pameijer; J P Binette
Journal:  Atherosclerosis       Date:  1980-10       Impact factor: 5.162

3.  Effect of degenerative spinal and aortic calcification on bone density measurements in post-menopausal women: links between osteoporosis and cardiovascular disease?

Authors:  L M Banks; B Lees; J E MacSweeney; J C Stevenson
Journal:  Eur J Clin Invest       Date:  1994-12       Impact factor: 4.686

4.  Bone morphogenetic protein expression in human atherosclerotic lesions.

Authors:  K Boström; K E Watson; S Horn; C Wortham; I M Herman; L L Demer
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo.

Authors:  J de la Mata; H L Uy; T A Guise; B Story; B F Boyce; G R Mundy; G D Roodman
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

6.  Bone and haematopoietic defects in mice lacking c-fos.

Authors:  Z Q Wang; C Ovitt; A E Grigoriadis; U Möhle-Steinlein; U Rüther; E F Wagner
Journal:  Nature       Date:  1992 Dec 24-31       Impact factor: 49.962

7.  Overexpression of the granulocyte colony-stimulating factor gene leads to osteoporosis in mice.

Authors:  T Takahashi; T Wada; M Mori; Y Kokai; S Ishii
Journal:  Lab Invest       Date:  1996-04       Impact factor: 5.662

8.  Genetic variability in adult bone density among inbred strains of mice.

Authors:  W G Beamer; L R Donahue; C J Rosen; D J Baylink
Journal:  Bone       Date:  1996-05       Impact factor: 4.398

Review 9.  Atherosclerotic calcification: relation to developmental osteogenesis.

Authors:  K Boström; K E Watson; W P Stanford; L L Demer
Journal:  Am J Cardiol       Date:  1995-02-23       Impact factor: 2.778

10.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.

Authors:  P Soriano; C Montgomery; R Geske; A Bradley
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

View more
  603 in total

Review 1.  Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors.

Authors:  B G Darnay; B B Aggarwal
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Genetics of atherosclerosis: the search for genes acting at the level of the vessel wall.

Authors:  V Villa-Colinayo; W Shi; J Araujo; A J Lusis
Journal:  Curr Atheroscler Rep       Date:  2000-09       Impact factor: 5.113

3.  RANK is essential for osteoclast and lymph node development.

Authors:  W C Dougall; M Glaccum; K Charrier; K Rohrbach; K Brasel; T De Smedt; E Daro; J Smith; M E Tometsko; C R Maliszewski; A Armstrong; V Shen; S Bain; D Cosman; D Anderson; P J Morrissey; J J Peschon; J Schuh
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

Review 4.  Vascular and valvar calcification: recent advances.

Authors:  A Farzaneh-Far; D Proudfoot; C Shanahan; P L Weissberg
Journal:  Heart       Date:  2001-01       Impact factor: 5.994

Review 5.  Ectopic calcification: gathering hard facts about soft tissue mineralization.

Authors:  C M Giachelli
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

6.  Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.

Authors:  S Cenci; M N Weitzmann; C Roggia; N Namba; D Novack; J Woodring; R Pacifici
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 7.  Regulation of osteoclast formation and function.

Authors:  L T Duong; G A Rodan
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 8.  Pathogenesis of postmenopausal osteoporosis.

Authors:  L G Raisz
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 9.  Osteoprotegerin.

Authors:  U Feige
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

10.  Cholesterol in vascular and valvular calcification.

Authors:  L L Demer
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.